Table of Conents

ENDOMETRIAL METAPLASIAS, HYPERPLASIAS, ADENOCARCINOMAS


ENDOMETRIAL ADENOCARCINOMAS; DISTINCTIVE FEATURES


Previous Slide Slide 8 Next Slide
7% of the invasive cancers in women.
Peak incidence at 55-65 years of age.
Increased risk is seen with obesity, infertility, hypertension, diabetes mellitus, and prolonged estrogen stimulation.
Clinically manifests as endometrial bleeding or may be discovered as a mass protruding from the endocervix during physical exam.